Meeting
2022 ASCO Annual Meeting
Clinical outcomes following termination of immunotherapy due to long-term benefit in MSI-H colorectal cancer.
Authors
Kristen Simmons
Baylor College of Medicine, Houston, TX
Kristen Simmons , Bryan K. Kee , Kanwal Pratap Singh Raghav , Benny Johnson , Scott Kopetz , Jason Willis , Arvind Dasari , Eduardo Vilar Sanchez , Kaysia Ludford , Christine Megerdichian Parseghian , Michael Sangmin Lee , Phat Le , John Paul Y.C. Shen , Michael J. Overman , Van K. Morris II
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3585)
DOI
10.1200/JCO.2022.40.16_suppl.3585
Abstract #
3585
Poster Bd #
379
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Impact of RAS mutations on immunologic characteristics of the tumor microenvironment (TME) in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC).
First Author: Mohamed E. Salem
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2019 ASCO Annual Meeting
Association of PIK3CA mutations (mut) with immune engagement and clinical benefit from immunotherapy in microsatellite stable (MSS) colorectal cancer (CRC) patients (pts).
First Author: Maliha Nusrat
Poster
2018 ASCO Annual Meeting
MSI-high and MSI-stable colorectal carcinomas (CRC): A comprehensive genomic profiling (CGP) study.
First Author: Siraj Mahamed Ali